Get Equity Tips
Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board
of Directors of the company will be held on February 17, 2016, inter
alia, to consider the Buyback of Equity Shares of the Company.
Stock commentary:
Dr Reddys Laboratories Ltd ended at Rs. 2886.85, down by Rs. 72.8 or 2.46% from its previous closing of Rs. 2959.65 on the BSE.
The scrip opened at Rs. 2920 and touched a high and low of Rs. 2935 and Rs. 2828 respectively. A total of 713535(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 49251.87 crore.
Stock commentary:
Dr Reddys Laboratories Ltd ended at Rs. 2886.85, down by Rs. 72.8 or 2.46% from its previous closing of Rs. 2959.65 on the BSE.
The scrip opened at Rs. 2920 and touched a high and low of Rs. 2935 and Rs. 2828 respectively. A total of 713535(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 49251.87 crore.
Dr Reddys Laboratories Ltd
BSE
2,950.90
64.05 (2.22%)
NSE
2,952.70
67.65 (2.34%)
The BSE group 'A' stock of face value Rs. 5 touched a 52 week high of
Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750 on 21-Jan-2016.
Last one week high and low of the scrip stood at Rs. 3123.3 and Rs.
2828 respectively.
The promoters holding in the company stood at 25.51 % while Institutions and Non-Institutions held 41.91 % and 14.35 % respectively. The stock traded above its 200 DMA.
